Saturday, February 21, 2026
18.4 C
Bengaluru

Doctors Still Considered Noble

Screen Shot 2016-07-03 at 5.35.50 am

[wpfilebase tag=file id=78 tpl=download-button /]

Inside this Issue

1. Five Disruptive Forces that are Shaking Up Pharma! by Piyush Agarwal
A curtain raiser on a few disruptions that will permanently alter the pharma marketing landscape in the near future.

2. The Dangers of Labelling Your Sales Team Members and Having a Closed Mindset by K. Hariram
It is easy to label your sales team members as inept but it closes the doors to improvement and progress.

3. 5 Leadership Lessons for Frontline Managers: Building an E2 Team by Vivek Hattangadi
How the pharma frontline manager can develop a high-performance team by fostering Empathy and Excellence in the team.

4. How to Hire a Future-Ready Field Force by Anjali Sharma and Chandan Kumar
As the pharma industry undergoes rapid change, the job roles and job descriptions of the sales force will also change. Hiring Managers need to keep this in mind.

5. Handling Sales Rejections Professionally by RB Balakrishna
How to handle sales rejections as a business problem to be solved rather than a personal affront.

6. Deciding on a Business Expansion Strategy by Weighing the Risks and Gains by Pankaj Mehrotra
An introduction to the use of the Ansoff Matrix to weigh the risks and the benefits of pursuing a particular growth strategy.

Hot this week

India’s Pharma Renaissance: Private Equity at the Helm

Indian pharmaceuticals have long been known as the “pharmacy...

The ₹5 Snack SKU: A Silent Indian Metabolic Crisis

Executive Summary — The Paradox of Scale In the annals...

Sleep Apnea: Apnimed Pill to Replace CPAP Machine?

In India, where urban sleep debt is rising, obesity...

Why the World Still Doesn’t Celebrate Antibiotic Breakthroughs llike Zaynich

When a new cancer drug shows promise, it trends...

From Overuse to Overreaction: Recalibrating India’s C-Section Debate

India’s caesarean section debate is drifting toward polarisation. On one...

Topics

India’s Pharma Renaissance: Private Equity at the Helm

Indian pharmaceuticals have long been known as the “pharmacy...

The ₹5 Snack SKU: A Silent Indian Metabolic Crisis

Executive Summary — The Paradox of Scale In the annals...

Sleep Apnea: Apnimed Pill to Replace CPAP Machine?

In India, where urban sleep debt is rising, obesity...

From Overuse to Overreaction: Recalibrating India’s C-Section Debate

India’s caesarean section debate is drifting toward polarisation. On one...

Sanofi’s Decision not to Renew Paul Hudson as CEO Marks a Structural Shift

In big pharma, leadership changes are rarely impulsive. They...

THE ENCUBE ETHICALS PLAYBOOK: FROM GOA WORKSHOP TO $2BN+ GLOBAL DEAL

How a niche Indian topicals manufacturer outgrew its CDMO...

Indian Pharma: Are Regulatory Gaps From Generics Following Biosimilars?

Transparency, Trust, and the Problem of “Invisible Evidence” in...
spot_img

Related Articles

spot_imgspot_img